Filtered By:
Condition: Diabetes
Procedure: Percutaneous Coronary Intervention
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 463 results found since Jan 2013.
Short Versus Long Duration of Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stents Implantation in Patients with Diabetes
CONCLUSION: This meta-analysis showed no statistically significant benefit of longer DAPT over shorter DAPT therapy in patients undergoing PCI with drug-eluting stent in patients with diabetes.PMID:35703185 | DOI:10.1097/MJT.0000000000001519
Source: Atherosclerosis - June 15, 2022 Category: Cardiology Authors: Manesh Kumar Gangwani Muhammad Aziz Paul Chacko Asif Mahmood Muhammad Ali Fnu Priyanka Siraj Munir Abeer Aziz Shazib Sagheer Wade Lee-Smith Om Parkash Devesh Rai Bipul Baibhav Wilbert S Aronow Source Type: research
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials
CONCLUSIONS: A history of symptomatic PAD still allows to simply identify patients with increased risk of unfavorable clinical outcome after PCI, including a higher risk of repeated coronary revascularization, despite using contemporary stents. In clinical practice, this knowledge about higher event risks of PAD patients is helpful both during Heart Team discussions and when informing patients about the procedural risk.PMID:35641327 | DOI:10.1016/j.atherosclerosis.2022.05.002
Source: Atherosclerosis - May 31, 2022 Category: Cardiology Authors: Tineke H Pinxterhuis Eline H Ploumen Paolo Zocca Carine J M Doggen Carl E Schotborgh Rutger L Anthonio Ariel Roguin Peter W Danse Edouard Benit Adel Aminian Martin G Stoel Gerard C M Linssen Robert H Geelkerken Clemens von Birgelen Source Type: research
Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome
CONCLUSION: Lp(a) was an independent predictor of revascularization in patients with ACS complicated with T2DM, regardless of LDL-C levels. This suggests that Lp(a) measurement may help identify high-risk diabetic patients with ACS.PMID:35575139 | DOI:10.1080/03007995.2022.2078080
Source: Current Medical Research and Opinion - May 16, 2022 Category: Research Authors: Yan Hao Yulin Yang Yongchao Wang Jian Li Source Type: research
Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention
CONCLUSION: The results of this study showed that adding low dose empagliflozin to standard care of ACS diabetic patients after PCI was associated with no significant reduction in negative cardiovascular outcomes during 6 months.PMID:35537720 | DOI:10.15537/smj.2022.43.5.20220018
Source: Saudi Medical Journal - May 10, 2022 Category: Middle East Health Authors: Seyed Mohammad H Adel Fateme Jorfi Hoda Mombeini Homeira Rashidi Saad Fazeli Source Type: research
